Diffuse lung diseases ascribed to drugs: a nationwide observational study over 37 years using the French Pharmacovigilance Database
This study from a large nationwide dataset spanning 37 years is the largest known to date. Drug-induced diffuse lung diseases are serious with a potentially fatal outcome. Accurate diagnoses remain essential to identify the diseases properly and discontinue the culprit drug urgently.
Authors
- Guillaume Beltramo (ORCID: https://orcid.org/0000-0003-2830-5642)
- Christine Le Beller
- Marjolaine Georges (ORCID: https://orcid.org/0000-0002-4659-5076)
- Kévin Bihan (ORCID: https://orcid.org/0000-0001-6797-0237)
- Sophie Yavordios
- F. Beau Salinas
- Philippe Bonniaud (ORCID: https://orcid.org/0000-0002-3670-5622)
- Aurélie Grandvuillemin (ORCID: https://orcid.org/0000-0001-6809-6975)
- Romane Freppel
- Pierre Mouillot
Institutions
- Inserm (FR)
- Université de Bourgogne (FR)
- Université Paris Cité (FR)
- Sorbonne Université (FR)
- Sorbonne Paris Cité (FR)
- La Ligue Contre le Cancer (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Hôpital Européen (FR)
- CHU Dijon Bourgogne (FR)
- Université Bourgogne Franche-Comté (FR)
- Zero to Three (US)
- Services déconcentrés d'appui à la recherche Val de Loire (FR)
- Centre de Recherche Saint-Antoine (FR)
- FHU Neurovasc (FR)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1183/13993003.00756-2024
- Citations
- 9
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 3.50